Top Nine Public Health Highlights of 2019
ASTHO CEO Michael Fraser looks back on nine of the top public health highlights in 2019.
ASTHO CEO Michael Fraser looks back on nine of the top public health highlights in 2019.
ASTHO interview with Elizabeth Harvey, PhD, MPH, a CDC Senior Maternal and Child Health Epidemiology Program assignee to the Tennessee Department of Health. Harvey shares her thoughts on the progress ...
Adopting a public health approach to substance use by implementing harm reduction policies across all levels of government can help communities address the overdose crisis. This post analyzes e
This report highlights key tools, resources, takeaways, and improvement strategies that health agencies can leverage to help navigate complex awards, increase efficiencies, and improve business ...
There are a number of court cases playing out across the country that could affect the options state and territorial health officials have to limit the spread of disease and promote health and ...
On this episode of Public Health Review, we speak with representatives from public health, public safety, and community harm reduction programs to discuss their perspectives, experiences, and the ...
In February 2019, ASTHO surveyed its members to understand how data is being utilized to address these harms in their jurisdictions. This brief summarizes the results of this survey and highlights ...
Opioid and substance use disorders (SUD) continue to affect families beyond pregnancy; in 2017, about one in eight U.S. children lived in a household where at least one parent had a SUD in the prior ...
Initial estimates from 2020 suggest that annual drug overdose deaths in the United States reached a record high of 93,000. Fortunately EMS strategies are being put in place to combat this nation-wide ...
This report highlights six public health approaches for addressing the rising incidence of substance use disorder and neonatal abstinence syndrome and draws out the critical role that state health ...
This brief outlines some of the barriers that pregnant and postpartum women with opioid use disorder face, as well as examples of state legislation passed to address recovery program implementation, ...
State and territorial health agencies continue to be challenged by the opioid epidemic, which has been exacerbated by the COVID-19 pandemic. Addressing the opioid crisis requires a robust public ...
This ASTHOReport builds on a 2020 document and reflects the current state and federal landscape regarding disruptions, shares updated recommendations on strategies states might use to mitigate risks ...
Four ways the Oregon Health Authority has benefited from aligning its opioid and accreditation-related efforts.
Xylazine: What Health Agencies Need to Know astho, association of state and territorial health officials, xylazine trend, xylazine, overdose epidemic, overdose deaths, harm reduction, drug overdose ...
With data showing the number of the opioid overdose deaths escalated during the COVID-19 pandemic, access to naloxone, a medication that can reverse an opioid overdose, continues to be an important ...
COVID-19 has elevated our nation’s stress level. When not managed properly (or without any buffers like social support) stress is associated with increased depression and anxiety. Because COVID-19 ...
The opioid crisis continues to claim the lives of thousands across the United States and has cost the economy billions in health care, mortality, and criminal justice costs. In 2018, it’s estimated ...
With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To ...
This brief describes how the New Mexico Department of Health has enhanced its harm reduction program to provide an evidence-based comprehensive care model to support the health of people who use ...